Tripotassium Dicitratobismuthate

A bismuth chelate effective in healing gastric and duodenal ulcers. A two week regimen containing tripotassium dicitratobismuthate plus a proton pump inhibitor plus two antibacterials may be effective in patients who have not responded to first-line regimens, it also prevents relapse of duodenal ulcer.

Brands
Adult Dose
Neonatal
Paedriatic
Characteristics
.
Contraindications
Tripotassium Dicitratobismuthate is contraindicated in conditions like Pregnancy,Renal impairment.
Effects
The symptomatic adverse reactions produced by Tripotassium Dicitratobismuthate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Darkening of stool and tongue, Nausea and vomiting.
Indications
Tripotassium Dicitratobismuthate is primarily indicated in conditions like Benign gastric ulcer, Duodenal ulcer, and can also be given in adjunctive therapy as an alternative drug of choice in Helicobacter pylori infection.
Interactions
No data regarding the interactions of Tripotassium Dicitratobismuthate was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.